Borrelial lymphocytoma cutis successfully treated with intralesional interferon-alpha-2A [25]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 8, 2006, Pages 1030-1032

  Aydogan, K ^a   Koran Karadogan, S ^a   Balaban Adim, S ^a   Tunali, S ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTIBIOTIC AGENT; B LYMPHOCYTE ANTIGEN; DOXYCYCLINE; PENICILLIN G;

ADULT; ANTIGEN EXPRESSION; BORRELIA BURGDORFERI; CASE REPORT; CLINICAL PROTOCOL; DISEASE DURATION; DNA SEQUENCE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LOW DRUG DOSE; LYMPHOCYTE; LYMPHOCYTOMA; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SKIN LYMPHOMA; SKIN NODULE; UNSPECIFIED SIDE EFFECT;

BORRELIA INFECTIONS; EAR, EXTERNAL; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PSEUDOLYMPHOMA; SKIN DISEASES, BACTERIAL;

EID: 33747332480     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01627.x     Document Type: Letter

References (10)

1. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol 1998; 38: 877-905.
2. Hovmark A, Asbirk E, Olsson I. The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm Venereol 1986; 66: 479-484.
3. Asbrink E, Howmark A. Early and late cutaneous manifestation in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme Borreliosis). Ann NY Acad Sci 1988; 539: 4-15.
4. Sigal LH. Lyme disease, 1988: Immunologic manifestations and possible immunopathogenic mechanisms. Semin Arthritis Rheum 1989; 18: 151-167.
5. Colli C, Leinweber B, Müllegger R, Chott A, Kerl H, Ceroni L. Borrelia burgdorferi-associated lymphocytoma cutis: Clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol 2004; 31: 232-240.
6. Kutting B, Bonsmann G, Metze D, Luger TA, Ceroni L. Borrelia burgdorferi- associated primary cutaneous B cell lymphoma: Complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection alfa-2a. J Am Acad Dermatol 1997; 36: 311-314.
7. Garbe C, Stein H, Dienemann D et al. Borrelia burgdorferi-associated cutaneous B cell lymphoma: Clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991; 24: 584-590.
8. Wollina U, Mentzel T, Graefe T. Large B-cell lymphoma of the leg-complete remission with perilesional interferon alpha. Dermatology 2001; 203: 165-167.
9. Kaisa H, Lehtinen T, Annikki V. Spiegler-fendt type lymphocytoma cutis: a case report of two patients successfully treated with interferon alpha-2b. Acta Derm Venereol 1999; 79: 241-242.
10. Lundgren E, Hoedman H, Landberg G et al. Molecular events in B cell activation and growth: Sensitivity to alpha interferon. Eur J Cancer 1991; 27: 82-84.